Could a single infusion ease the burden of long COVID?
NCT ID NCT05877508
Summary
This study is testing whether a one-time infusion of a lab-made antibody (AER002) can help people with Long COVID feel better. About 30 adults with persistent symptoms after a COVID-19 infection will receive either the antibody treatment or a placebo. Researchers will track changes in physical health, fatigue, brain fog, and quality of life over a year to see if the treatment is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF/Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.